1. Home
  2. RUSHA vs DFTX Comparison

RUSHA vs DFTX Comparison

Compare RUSHA & DFTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rush Enterprises Inc. Cl A

RUSHA

Rush Enterprises Inc. Cl A

HOLD

Current Price

$78.55

Market Cap

5.6B

ML Signal

HOLD

Logo Definium Therapeutics Inc. Common Shares

DFTX

Definium Therapeutics Inc. Common Shares

N/A

Current Price

$45.83

Market Cap

5.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RUSHA
DFTX
Founded
1965
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.9B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
RUSHA
DFTX
Price
$78.55
$45.83
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$76.75
$38.50
AVG Volume (30 Days)
472.8K
2.1M
Earning Date
04-28-2026
05-04-2026
Dividend Yield
1.06%
N/A
EPS Growth
N/A
N/A
EPS
1.68
N/A
Revenue
$7,434,195,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.44
N/A
P/E Ratio
$46.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$45.67
$14.62
52 Week High
$83.61
$49.70

Technical Indicators

Market Signals
Indicator
RUSHA
DFTX
Relative Strength Index (RSI) 45.29 55.44
Support Level $70.00 $40.46
Resistance Level $80.17 $45.42
Average True Range (ATR) 1.98 2.75
MACD -0.63 -0.07
Stochastic Oscillator 6.71 50.77

Price Performance

Historical Comparison
RUSHA
DFTX

About RUSHA Rush Enterprises Inc. Cl A

Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.

About DFTX Definium Therapeutics Inc. Common Shares

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

Share on Social Networks: